BRAF and melanoma: Lastly, Straussman and colleagues reported sustained activation of both ERK and AKT inHGF-treated melanoma cells during BRAF inhibition and to a lesser extent MEK inhibition,as shown in Figure 4C and Supplemental Figure 19 by Western blot.